非洲Pfkelch13基因多态性的空间与分子图谱:青蒿素耐药浮现时代的系统综述
作者认为非洲已报告耐药相关突变,分子标记监测可为维持青蒿素有效性提供决策信息。
要点
- 9种与东南亚青蒿素耐药相关的Pfkelch13突变已在非洲检出,主要在东非。
- 建议用PfART-R分子标记开展监测,以维持青蒿素在非洲的有效性。
核心结论
- 非洲虽被认为尚未建立青蒿素耐药,但过去5年已报告与耐药相关的Pfkelch13突变。
- 利用PfART-R分子标记进行监测可为维持青蒿素有效性提供有价值的决策信息。
研究设计与样本
- 系统综述,检索PubMed、Embase、Scopus、African Journal Online、African Index Medicus、Bioline和Web of Science共7个数据库,截止2019年1月。
主要发现
- Pfkelch13序列高度多态,共292个等位基因,其中255个位于Pfkelch13-propeller结构域。
- 按WHO标准,检测到9种与东南亚青蒿素耐药相关的突变(Phe446Ile、Cys469Tyr、Met476Ile、Arg515Lys、Ser522Cys、Pro553Leu、Val568Gly、Pro574Leu和Ala675Val),主要见于东非。
- 还鉴定出若干其他Pfkelch13突变,结构上与东南亚PfART-R突变相似,但其与耐药的相关性尚不清楚。
关键数值与推荐
- 与东南亚PfART-R相关的9种Pfkelch13突变已在非洲检出,主要位于东非。
临床怎么用
- 在非洲应用PfART-R分子标记开展监测,为青蒿素使用决策提供依据。
- 对结构相似但耐药相关性未知的Pfkelch13突变,需进一步评估其耐药意义。
局限性
- 文献检索截止2019年1月,未涵盖此后新发表的数据。
- 部分鉴定的Pfkelch13突变与耐药的相关性尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The spread of Plasmodium falciparum isolates carrying mutations in the kelch13 (Pfkelch13) gene associated with artemisinin resistance (PfART-R) in southeast Asia threatens malaria control and elimination efforts. Emergence of PfART-R in Africa would result in a major public health problem. In this systematic review, we investigate the frequency and spatial distribution of Pfkelch13 mutants in Africa, including mutants linked to PfART-R in southeast Asia. Seven databases were searched (PubMed, Embase, Scopus, African Journal Online, African Index Medicus, Bioline, and Web of Science) for relevant articles about polymorphisms of the Pfkelch13 gene in Africa before January, 2019. Following PRISMA guidelines, 53 studies that sequenced the Pfkelch13 gene of 23 100 sample isolates in 41 sub-Saharan African countries were included. The Pfkelch13 sequence was highly polymorphic (292 alleles, including 255 in the Pfkelch13-propeller domain) but with mutations occurring at very low relative frequencies. Non-synonymous mutations were found in only 626 isolates (2·7%) from west, central, and east Africa. According to WHO, nine different mutations linked to PfART-R in southeast Asia (Phe446Ile, Cys469Tyr, Met476Ile, Arg515Lys, Ser522Cys, Pro553Leu, Val568Gly, Pro574Leu, and Ala675Val) were detected, mainly in east Africa. Several other Pfkelch13 mutations, such as those structurally similar to southeast Asia PfART-R mutations, were also identified, but their relevance for drug resistance is still unknown. This systematic review shows that Africa, thought to not have established PfART-R, reported resistance-related mutants in the past 5 years. Surveillance using PfART-R molecular markers can provide valuable decision-making information to sustain the effectiveness of artemisinin in Africa.
引用
- Kayiba NK, Yobi DM, Tshibangu-Kabamba E, et al. Spatial and molecular mapping of Pfkelch13 gene polymorphism in Africa in the era of emerging Plasmodium falciparum resistance to artemisinin: a systematic review. Lancet Infect Dis. 2020. PMID: 33125913. doi:10.1016/S1473-3099(20)30493-X
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。